{"id":589187,"date":"2022-03-02T15:20:01","date_gmt":"2022-03-02T15:20:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=589187"},"modified":"2022-03-02T15:20:01","modified_gmt":"2022-03-02T15:20:01","slug":"leigh-syndrome-market-to-exhibit-moderate-growth-rate-till-2032-investigates-delveinsight-key-companies-aadi-bioscience-khondrion-and-ptc-therapeutics","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/leigh-syndrome-market-to-exhibit-moderate-growth-rate-till-2032-investigates-delveinsight-key-companies-aadi-bioscience-khondrion-and-ptc-therapeutics_589187.html","title":{"rendered":"Leigh Syndrome Market to Exhibit Moderate Growth Rate till 2032, Investigates DelveInsight | Key Companies – Aadi Bioscience, Khondrion, and PTC Therapeutics"},"content":{"rendered":"
\n
\"Leigh<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “Leigh Syndrome Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Leigh Syndrome Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/div>\n

The Leigh Syndrome market report<\/strong> covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

\"Leigh<\/p>\n

Leigh Syndrome: An Overview<\/strong><\/p>\n

Leigh syndrome is a rare, inherited neurodegenerative condition. It usually becomes apparent in infancy, often after a viral infection.<\/em><\/p>\n

The first signs of Leigh syndrome seen in infancy are usually vomiting, diarrhea, and difficulty swallowing (dysphagia), disrupting eating. These problems often result in an inability to grow and gain weight at the expected rate (failure to thrive). Severe muscle and movement problems are common in Leigh syndrome. <\/em><\/p>\n

A thorough clinical evaluation may confirm the diagnosis of Leigh syndrome and a variety of specialized tests, particularly advanced imaging techniques. Magnetic resonance imaging (MRI) or computed tomography (CT) scans of the brain may reveal abnormal areas in certain parts of the brain (i.e., basal ganglia, brain stem, and gray matter). An MRI uses a magnetic field and radio waves to produce cross-sectional images of particular organs and bodily tissues. During CT scanning, a computer and x-rays are used to create a film showing cross-sectional images of certain tissue structures.<\/em><\/p>\n

Leigh Syndrome Market Key Facts<\/strong><\/p>\n